|
Thermo Fisher
surface plasmon resonance spr Surface Plasmon Resonance Spr, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/bio_rxiv__64898__2026__01__27__701919-28-3-9?v=Thermo+Fisher Average 94 stars, based on 1 article reviews
surface plasmon resonance spr - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Tokyo Chemical Industry
spiramycin Spiramycin, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/pm41951099-83-31-38?v=Tokyo+Chemical+Industry Average 86 stars, based on 1 article reviews
spiramycin - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Merial
spiramycin Spiramycin, supplied by Merial, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/pm41910925-65-3-7?v=Merial Average 86 stars, based on 1 article reviews
spiramycin - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Sanofi
reference drug spiramycin tablets Reference Drug Spiramycin Tablets, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/pm41285946-105-0-5?v=Sanofi Average 86 stars, based on 1 article reviews
reference drug spiramycin tablets - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Sanofi
spiramycin tablets ![]() Spiramycin Tablets, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/pmc12647587-88-0-3?v=Sanofi Average 86 stars, based on 1 article reviews
spiramycin tablets - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Sanofi
spiramycin ![]() Spiramycin, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/pm41230266-26-0-3?v=Sanofi Average 86 stars, based on 1 article reviews
spiramycin - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Liofilchem
spiramycin ![]() Spiramycin, supplied by Liofilchem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/pmc12448149-47-7-15?v=Liofilchem Average 86 stars, based on 1 article reviews
spiramycin - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Toronto Research Chemicals
spiramycin d3 ![]() Spiramycin D3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/spiramycin/10__1016_slash_j__afres__2025__101095-61-3-21?v=Toronto+Research+Chemicals Average 93 stars, based on 1 article reviews
spiramycin d3 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
Journal: Scientific Reports
Article Title: Exploring the role of chitosan and curcumin-loaded chitosan nanoparticles against chronic toxoplasma infection in experimental mice
doi: 10.1038/s41598-025-25252-5
Figure Lengend Snippet: Bradyzoite Stages of Toxoplasma gondii in mouse brain stained with Giemsa in different treatment groups (n = 6 samples/group); scale bar = 20μm. ( a ) Bradyzoite in the infected-untreated group. ( b ) Bradyzoite in the Spiramycin treated group. ( c ) Bradyzoite in the CSNPs treated group. ( d ) Bradyzoites in the Cur-CSNPs treated group exhibited a significant reduction in cyst size ( P = 0.001) compared to other treated groups, whereas no statistically significant difference was observed between other groups ( P > 0.05).
Article Snippet:
Techniques: Staining, Infection
Journal: Scientific Reports
Article Title: Exploring the role of chitosan and curcumin-loaded chitosan nanoparticles against chronic toxoplasma infection in experimental mice
doi: 10.1038/s41598-025-25252-5
Figure Lengend Snippet: Photomicrograph of brain tissue sections (n = 6 samples/group) stained with hematoxylin and eosin from Spiramycin-treated group ( A , B ) demonstrating congested blood vessel (curved arrow), and neuronal degeneration (arrow), CSNPs-treated group ( C , D ) demonstrating tissue cyst (square), congested blood vessel (asterisk), and neuronal degeneration (arrow), inset is high magnification, and Cu-CSNPs-treated group ( E , F ) demonstrating apparently normal appearance of neurons (arrow) and glia cells (curved arrow). CSNPs: Chitosan nanoparticles-treated group; Cur-CSNPs: curcumin-loaded Chitosan nanoparticles-treated group.
Article Snippet:
Techniques: Staining
Journal: Scientific Reports
Article Title: Exploring the role of chitosan and curcumin-loaded chitosan nanoparticles against chronic toxoplasma infection in experimental mice
doi: 10.1038/s41598-025-25252-5
Figure Lengend Snippet: Photomicrograph of liver tissue sections (n = 6 samples/group) stained with hematoxylin and eosin from Spiramycin-treated group ( A , B ) demonstrating slight infiltration of mononuclear cells in portal areas (arrow), CSNPs-treated group ( C , D ) demonstrating tissue cysts (wavy arrow) and vascular congestion (asterisk) with perivascular inflammatory cells infiltration (arrow), and Cu-CSNPs-treated group ( E , F ) demonstrating normal structure of the hepatic parenchyma with mild vascular congestion (asterisk) in some examined lobules. CSNPs: Chitosan nanoparticles-treated group; Cur-CSNPs: curcumin-loaded Chitosan nanoparticles-treated group.
Article Snippet:
Techniques: Staining
Journal: Scientific Reports
Article Title: Exploring the role of chitosan and curcumin-loaded chitosan nanoparticles against chronic toxoplasma infection in experimental mice
doi: 10.1038/s41598-025-25252-5
Figure Lengend Snippet: Photomicrograph of spleen tissue sections (n = 6 samples/group) stained with hematoxylin and eosin from negative control ( A – C ), infected-untreated ( D – F ), Spiramycin-treated ( G – I ), CSNPs-treated ( J – L ), and Cur-CSNPs-treated groups ( M – O ). (RP) red pulp, (WP) white pulp, (M) megakaryocytes, (arrow) lymphoid necrosis, (curved arrow) lymphoid depletion, (arrowhead) congestion, (wavy arrow) perifollicular hemorrhage, and (asterisk) hemorrhage in red pulp. CSNPs: Chitosan nanoparticles-treated group; Cur-CSNPs: curcumin-loaded Chitosan nanoparticles-treated group.
Article Snippet:
Techniques: Staining, Negative Control, Infection
Journal: Scientific Reports
Article Title: Exploring the role of chitosan and curcumin-loaded chitosan nanoparticles against chronic toxoplasma infection in experimental mice
doi: 10.1038/s41598-025-25252-5
Figure Lengend Snippet: Immuno-expression of IL-6 in brain, liver, and spleen tissues. The anti-IL-6 antibodies demonstrate a strong and extensive, brown-colored expression in brain, liver, and spleen of the infected-untreated mice compared to their moderate expression in Spiramycin- and CSNPs- treated groups and weak expression in negative control and Cu-CSNPs-treated group. CSNPs: Chitosan nanoparticles-treated group; Cur-CSNPs: curcumin-loaded Chitosan nanoparticles-treated group.
Article Snippet:
Techniques: Expressing, Infection, Negative Control
Journal: Scientific Reports
Article Title: Exploring the role of chitosan and curcumin-loaded chitosan nanoparticles against chronic toxoplasma infection in experimental mice
doi: 10.1038/s41598-025-25252-5
Figure Lengend Snippet: Immuno-expression of TNF-α in brain, liver, and spleen tissues. The anti-TNF-α antibodies demonstrate a strong and extensive, brown-colored expression in brain, liver, and spleen of the infected-untreated mice compared to their moderate expression in Spiramycin- and CSNPs- treated groups and weak expression in control negative and Cu-CSNPs-treated group. CSNPs: Chitosan nanoparticles-treated group; Cur-CSNPs: curcumin-loaded Chitosan nanoparticles-treated group.
Article Snippet:
Techniques: Expressing, Infection, Control